Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Roots Analysis | PRODUCT CODE: 1068656

Cover Image

PUBLISHER: Roots Analysis | PRODUCT CODE: 1068656

Women's Digital Health Market by Type of Solutions (Applications / Software, Devices and Services), Therapeutic Application Areas (Fetal Health, General Wellness, Menstrual Cycle, Pelvic Care, Reproductive Health / Fertility,

PUBLISHED:
PAGES: 294 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4799
PDF (One-Location Site License)
USD 6999
PDF (Department License)
USD 10599
PDF (Enterprise License)
USD 17999

Add to Cart

Title:
Women's Digital Health
Market by Type of Solutions (Applications / Software, Devices and Services), Therapeutic Application Areas (Fetal Health, General Wellness, Menstrual Cycle, Pelvic Care, Reproductive Health / Fertility, and Other Therapeutic Areas), and Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa): Industry Trends and Global Forecasts, 2022-2035.

Example Insights:

Overview

Over the past few years, there have been several advancements in the field of digital health market; this has led to an increase in the adoption of digital healthcare solutions. Specifically, the outbreak of COVID-19 pandemic prompted people all over the world to rely on digital medium to receive healthcare remotely. Females constitute 49.6% of the world's total population and, in one of its reports, the US department of labor reported that females use digital health care solutions more than men. Further, in a recent survey, it was founded that the percentage of women adopting tele health platform rose from 13% to 38% post the outbreak of COVID-19. Currently, there are more than 100 marketed solutions focused on women's digital health; these include applications, software and devices. Some of these solutions have also been approved by the USFDA for therapeutic applications in areas, such as reproductive health and menstrual health. It is worth noting that, NC° Birth Control, developed by Natural Cycles, was the first application to receive approval from US FDA in 2018; the application can be used as a method of contraception and helps in regularly tracking menstrual cycle.

Several developers are actively engaged in the development of solutions related to women's digital health. In fact, a number of start-ups focused on women's digital health have been established in the last few years, indicating the growing interest in this sector. A variety of solutions, such as women's health diagnostic devices, women's health applications as well as digital services for women, primarily targeting reproductive health, menstrual health, pelvic floor care and fetal health, are being developed by digital women's health solution providers. Owing to the fact that women's digital health is a relatively niche field, extensive research and development is required in order to meet the existing unmet needs of women. Having said that, the domain has attracted significant attention from the investors and healthcare venture capitalists, which have invested close to USD 3 billion over the past few years, enabling the femtech business flourish. Given the increasing research efforts and active involvement of investors, we expect a variety of applications and devices focused on improving women's health to be developed, enabling the women's digital health market to witness steady growth over the coming years.

Scope of the Report

The "Women's Digital Health Market by Type of Solutions (Applications / Software, Devices and Services), Therapeutic Application Areas (Fetal Health, General Wellness, Menstrual Cycle, Pelvic Care, Reproductive Health / Fertility, and Other Therapeutic Areas), and Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa): Industry Trends and Global Forecasts, 2022-2035" report features an extensive study on the current market landscape, offering an informed opinion on the likely future potential of women's digital health solution providers, over the next decade. The study underlines an in-depth analysis, highlighting the diverse capabilities of various industry stakeholders engaged in this field. In addition to other elements, the report includes:

  • A detailed assessment of the overall market landscape of women's digital health solution providers along with the information on their year of establishment, company size, location of headquarters, type of solution(s) offered (applications / software, devices and services) . In addition to this, the chapter provides details on the type of solution(s) offered along with information on their current status of development, ratings, therapeutic application area, usage period with respect to pregnancy, purpose and end-users.
  • Detailed profiles of key players engaged in the women's digital health market (shortlisted on the basis of company size) . Each profile features a brief overview of the company, its financial information (if available), details on the solution(s) offered, recent developments and an informed future outlook.A detailed analysis of the various funding and investments made since 2016, including venture capital financing, secondary offering, private placement, grant, debt financing and other equity in the companies focused on offering solutions for women's digital health.
  • An analysis of the partnerships that have been established in this domain since 2015, covering commercialization agreements, distribution agreements, licensing and distribution agreements, product / technology integration agreements, product development agreements, service agreements, manufacturing agreements, R&D agreements, and product development and commercialization agreements.
  • An analysis of the start-ups / small players (established in the last ten years, with less than 50 employees) engaged in the women's digital health market, featuring spider web representations based on several relevant parameters, such as number of solution(s) offered, therapeutic application areas, usage period with respect to pregnancy, details on funding (including funding amount, and evolution of investment activity) and partnership activity.
  • A detailed analysis of the global events attended by the participants, based on several relevant parameters, such as year of event, type of event platform, location of event, emerging focus areas, active organizers (in terms of number of events), active industry and non-industry participants, designation of participants, affiliated department of participant, active speakers (in terms of number of events). Additionally, the chapter highlights geographical mapping of the upcoming events.
  • A roadmap for the development of women's digital health solutions, such as applications and devices considering various factors that impact pre-development, development and post-development process. It also highlights the current unmet needs in digital health solutions for women across different therapeutic application areas.

One of the key objectives of the report was to understand the primary growth drivers and estimate the potential opportunities for the women's digital health market. We have provided an informed estimate of the evolution of women's digital health market for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented across type of solution(s) (applications / software, devices and services offered / available), therapeutic application area (fetal health, general wellness, menstrual cycle, pelvic area, reproductive health / fertility and others) and key geographies (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.

The opinions and insights presented in the report were influenced by discussions held with several stakeholders in the industry. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order):

  • Maryam Ziaei (Founder and Chief Executive Officer, iSONO Health)
  • Ann Garnier (Founder and Chief Executive Officer, Lisa Health)
  • Honny Hillegonda Kipnis Groen (Chief Marketing Officer, Illumigyn)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered:

  • Who are the leading industry players offering solutions for women's digital health?
  • Which women's digital health applications and devices have been approved by the FDA?
  • What kind of partnership models are commonly adopted by industry and non-industry stakeholders?
  • Who are the key investors active in the field of women's digital health?
  • What is the focus of global events / conferences held for women's digital health?
  • What is the roadmap for the development of women's digital health solutions?
  • What are the various unmet needs across different therapeutic application areas in the current women's digital health market?
  • How is the current and future opportunity related to women's digital health likely to be distributed across key market segments?

Chapter Outlines

Chapter 2 provides an executive summary of the key insights captured during our research. It offers a high-level view on the current status of women's digital health market and its likely evolution in the short to mid-term and long term.

Chapter 3 provides a general introduction to the women's digital health sector, along with information on wearable devices, mobile applications and services for monitoring / diagnosis, providing details related to the current and future trends affiliated to the domain. Further, it includes a brief discussion on importance of femtech industries in women's healthcare. The chapter also highlights key concepts involved in the development of women' digital health, featuring discussion on challenges faced during the development of women's digital healthcare.

Chapter 4 provides an overall market landscape of women's digital health solution providers along with the information on their year of establishment, company size, location of headquarters, type of solution(s) offered (applications / software, devices and services). In addition to this, the chapter provides details on the type of solution(s) offered along with information on their current status of development, ratings, therapeutic application area, usage period with respect to pregnancy, purpose and end-users.

Chapter 5 includes detailed profiles of the key players based in North America that are engaged in the women's digital health market. Each profile features a brief overview of the company, its financial information (if available), details on its product portfolio, recent developments and an informed future outlook.

Chapter 6 includes detailed profiles of the key players based in Europe, Asia-Pacific, and Middle East and North Africa that are engaged in the women's digital health market. Each profile features a brief overview of the company, its financial information (if available), details on its product portfolio, recent developments and an informed future outlook.

Chapter 7 presents detailed analysis of the various funding and investments made since 2016, including venture capital financing, secondary offering, private placement, grant, debt financing and other equity in the companies focused on offering solutions for women's digital health.

Chapter 8 features an insightful analysis of the partnerships that have been established in this domain since 2015, covering commercialization agreements, distribution agreements, licensing and distribution agreements, product / technology integration agreements, product development agreements, service agreements, manufacturing agreements, R&D agreements, and product development and commercialization agreements.

Chapter 9 includes an analysis of the start-ups / small players (established in the last ten years, with less than 50 employees) engaged in the women's digital health market, featuring heat map representation based on several relevant parameters, such as number of solution(s) offered, therapeutic application areas, usage period with respect to pregnancy, details on funding (including funding amount, and evolution of investment activity) and partnership activity.

Chapter 10 includes the global events attended by the participants, based on several relevant parameters, such as year of event, type of event platform, location of event, emerging focus areas, active organizers (in terms of number of events), active industry and non-industry participants, designation of participants, affiliated department of participant, active speakers (in terms of number of events). Additionally, the chapter highlights geographical mapping of the upcoming events.

Chapter 11 provides information on the affiliated trends, key drivers and challenges associated with women's digital health solutions, under a reliable SWOT framework. Further, the chapter includes a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall women's digital health market.

Chapter 12 features roadmap for the development of women's digital health solutions, such as applications and devices considering various factors that impact pre-development, development and post-development process. It also highlights the current unmet needs in digital health solutions for women across different therapeutic application areas.

Chapter 13 features an insightful market forecast analysis, highlighting the likely growth of the women's digital health solution market for the time period 2022-2035. In order to provide details on the future outlook, our year-wise projections of the current and future opportunity have further been segmented across type of solution(s) (applications / software, devices and services offered / available), therapeutic application area (fetal health, general wellness, menstrual cycle, pelvic area, reproductive health / fertility and others) and key geographies (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa).

Chapter 14 provides a general overview on the role of digitalization in women's life and the impact of COVID-19 on the adoption of digital health solutions among women. The chapter also includes a discussion on the usage of digital solutions by women for learning new skills, and stepping forward in personal and professional life, the existing gender gap and impact of AI in order to resolve the challenges associated with gender gap.

Chapter 15 provides a general overview on adoption of digital medium in healthcare sector, including information on artificial intelligence, machine learning, deep learning and metaverse, covering details related to the current and future trends affiliated to the domain. Further, it includes companies engaged in using artificial intelligence and machine learning in healthcare solutions. In addition to this, the chapter includes discussion on how digital mediums will reshape the future of the medical industry.

Chapter 16 summarizes the entire report, highlighting various facts related to contemporary market trends and the likely evolution of the women's digital health market.

Chapter 17 is a collection of interview transcripts of discussions held with various key stakeholders in this market. In this chapter, we have presented detailed transcripts of interviews held with (in alphabetical order) Maryam Ziaei (Founder and Chief Executive Officer, iSONO Health) , Ann Garnier (Founder and Chief Executive Officer, Lisa Health) and Honny Hillegonda Kipnis Groen (Chief Marketing Officer, Illumigyn)

Chapter 18 is an appendix that contains tabulated data and numbers for all the figures in the report.

Chapter 19 is an appendix that provides the list of companies and organizations mentioned in the report.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Introduction to Digital Health
  • 3.3. Women's Digital Health
  • 3.4. Importance of Women's Digital Health
  • 3.5. Challenges Related to Women's Digital Health
  • 3.6. Future Perspectives

4. MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2 Women's Digital Health: Product Pipeline
    • 4.2.1 Analysis by Type of Solution
    • 4.2.2 Analysis by Current Status of Development
    • 4.2.3 Analysis of Women's Digital Health Applications by Ratings
    • 4.2.4 Analysis by Therapeutic Application Area
    • 4.2.5 Analysis by Usage Period with respect to Pregnancy
    • 4.2.6 Analysis by Purpose
    • 4.2.7 Analysis by End-Users
    • 4.2.8 Analysis by Therapeutic Application Area and Type of Solution
  • 4.3 Women's Digital Health: Developer Landscape
    • 4.3.1 Analysis by Year of Establishment
    • 4.3.2 Analysis by Company Size
    • 4.3.3 Analysis by Region of Headquarters
    • 4.3.4 Analysis by Company Size and Region of Headquarters
    • 4.3.5 Analysis by Location of Headquarters
    • 4.3.6 Leading Players: Analysis by Number of Solutions
    • 4.3.7 Regional Landscape: Analysis by Type of Solution

5. WOMEN'S DIGITAL HEALTH DEVELOPERS IN NORTH AMERICA: COMPANY PROFILES

  • 5.1. Chapter Overview
  • 5.2. Garmin
    • 5.2.1. Company Overview
    • 5.2.2. Product / Service Portfolio
    • 5.2.3. Women's Digital Health Product / Service(s) Offered
    • 5.2.4. Recent Developments and Future Outlook
  • 5.3. Kindbody
    • 5.3.1. Company Overview
    • 5.3.2. Product / Service Portfolio
    • 5.3.3. Women's Digital Health Product / Service(s) Offered
    • 5.3.4. Recent Developments and Future Outlook
  • 5.4. LetsGetChecked
    • 5.4.1. Company Overview
    • 5.4.2. Product / Service Portfolio
    • 5.4.3. Women's Digital Health Product / Service(s) Offered
    • 5.4.4. Recent Developments and Future Outlook
  • 5.5. Maven Clinic
    • 5.5.1. Company Overview
    • 5.5.2. Product / Service Portfolio
    • 5.5.3. Women's Digital Health Product / Service(s) Offered
    • 5.5.4. Recent Developments and Future Outlook
  • 5.6. Ro
    • 5.6.1. Company Overview
    • 5.6.2. Product / Service Portfolio
    • 5.6.3. Women's Digital Health Product / Service(s) Offered
    • 5.6.4. Recent Developments and Future Outlook
  • 5.7. Willow Innovations
    • 5.7.1. Company Overview
    • 5.7.2. Product / Service Portfolio
    • 5.7.3. Women's Digital Health Product / Service(s) Offered
    • 5.7.4. Recent Developments and Future Outlook

6. WOMEN'S DIGITAL HEALTH DEVELOPERS IN EUROPE, ASIA-PACIFIC AND MIDDLE EAST & NORTH AFRICA: COMPANY PROFILES

  • 6.1. Chapter Overview
  • 6.2. Flo Health
    • 6.2.1. Company Overview
    • 6.2.2. Product / Service Portfolio
    • 6.2.3. Women's Digital Health Product / Service(s) Offered
    • 6.2.4. Recent Developments and Future Outlook
  • 6.3. Hubble Connected
    • 6.3.1. Company Overview
    • 6.3.2. Product / Service Portfolio
    • 6.3.3. Women's Digital Health Product / Service(s) Offered
    • 6.3.4. Recent Developments and Future Outlook
  • 6.4. International Medical Center
    • 6.4.1. Company Overview
    • 6.4.2. Product / Service Portfolio
    • 6.4.3. Women's Digital Health Product / Service(s) Offered
    • 6.4.4. Recent Developments and Future Outlook

7. FUNDING AND INVESTMENT ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Types of Funding
  • 7.3. Women's Digital Health: Funding and Investment Analysis
    • 7.3.1. Analysis by Year, Type of Funding and Amount Invested
    • 7.3.2. Analysis by Year of Investment
    • 7.3.3. Analysis by Amount Invested
    • 7.3.4. Analysis by Type of Funding
    • 7.3.5. Analysis by Type of Funding and Amount Invested
    • 7.3.6. Most Active Players: Analysis by Number of Funding Instances
    • 7.3.7. Most Active Players: Analysis by Amount Raised
    • 7.3.8. Key Investors: Analysis by Number of Instances
    • 7.3.9. Analysis by Type of Solution
    • 7.3.10. Analysis by Type of Solution and Amount Invested
    • 7.3.11. Analysis by Therapeutic Application Area
    • 7.3.12. Analysis by Geography
    • 7.3.13. Analysis by Year, Therapeutic Application Area and Amount Invested
    • 7.3.14. Summary of Investments

8. PARTNERSHIPS AND COLLABORATIONS

  • 8.1. Chapter Overview
  • 8.2 Partnership Models
  • 8.3. List of Partnerships and Collaborations
    • 8.3.1. Analysis by Year of Partnership
    • 8.3.2. Analysis by Type of Partnership
    • 8.3.3. Analysis by Product / Solution
    • 8.3.4. Analysis by Type of Partner
    • 8.3.5. Analysis by Year of Partnership and Type of Partner
    • 8.3.6. Analysis by Type of Partnership and Product / Solution
    • 8.3.7. Most Active Players: Analysis by Number of Partnerships
    • 8.3.8. Leading Players: Analysis by Type of Partnership
    • 8.3.9. Regional Analysis
    • 8.3.10. Intercontinental and Intracontinental Agreements

9. START UP HEALTH INDEXING

  • 9.1. Chapter Overview
  • 9.2. Scope and Methodology
  • 9.3. Benchmarking of Start-ups
    • 9.3.1. Analysis by Type of Product / Solution
    • 9.3.2. Analysis by Therapeutic Application Area
    • 9.3.3. Analysis by Usage Period with respect to Pregnancy
    • 9.3.4 Analysis by Partnership Activity
    • 9.3.5. Analysis by Funding Activity
    • 9.3.6. Analysis by Progression of Funding
    • 9.3.7. Analysis by Type of Funding
    • 9.3.8. Analysis by Location of Headquarters
    • 9.3.9. Start-up Health Indexing: Roots Analysis Perspective

10. GLOBAL EVENTS ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Scope and Methodology
  • 10.3. Global Events related to Women's Digital Health
    • 10.3.1. Analysis by Year of Event
    • 10.3.2. Analysis by Event Platform
    • 10.3.3. Analysis by Type of Event
    • 10.3.4. Analysis by Geography
    • 10.3.5. Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Areas
    • 10.3.6. Most Active Event Organizers: Analysis by Number of Events
    • 10.3.7. Most Active Participants: Analysis by Number of Events
    • 10.3.8. Analysis by Seniority Level of Participants
    • 10.3.9. Most Active Speakers: Analysis by Number of Events
    • 10.3.10. Geographical Mapping of Upcoming Events

11. SWOT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Women's Digital Health: SWOT Analysis
    • 11.2.1. Comparison of SWOT Factors
      • 11.2.1.1. Strengths
      • 11.2.1.2. Weaknesses
      • 11.2.1.3. Opportunities
      • 11.2.1.4. Threats

12. PRODUCT DEVELOPMENT AND SUCCESS ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Scope and Methodology
  • 12.3. Roadmap for the Development of Women's Digital Health Application
    • 12.3.1. Application Development and Success Analysis: Pre-Development Parameters
    • 12.3.2. Application Development and Success Analysis: Development Parameters
    • 12.3.3. Application Development and Success Analysis: Post-Development Parameters
  • 12.4. Roadmap for the Development of Women's Digital Health Device
    • 12.4.1. Device Development and Success Analysis: Pre-Development Parameters
    • 12.4.2. Device Development and Success Analysis: Development Parameters
    • 12.4.3. Device Development and Success Analysis: Post-Development Parameters
  • 12.5. Women's Digital Health: Unmet Needs

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

  • 13.1. Chapter Overview
  • 13.2. Forecast Methodology and Key Assumptions
  • 13.3. Overall Women's Digital Health Market, 2022-2035
    • 13.3.1. Women's Digital Health Market, 2022-2035: Distribution by Type of Solution
      • 13.3.1.1. Women's Digital Health Market for Applications / Software, 2022-2035
      • 13.3.1.2. Women's Digital Health Market for Devices, 2022-2035
      • 13.3.1.3. Women's Digital Health Market for Services Offered / Available, 2022-2035
    • 13.4.1. Women's Digital Health Market for Applications / Software, 2022-2035: Distribution by Therapeutic Application Area
      • 13.4.1.1. Women's Digital Health Applications / Software Market for Fetal Health, 2022-2035
      • 13.4.1.2. Women's Digital Health Applications / Software Market for General Wellness, 2022-2035
      • 13.4.1.3. Women's Digital Health Applications / Software Market for Menstrual Cycle, 2022-2035
      • 13.4.1.4. Women's Digital Health Applications / Software Market for Pelvic Care, 2022-2035
      • 13.4.1.5. Women's Digital Health Applications / Software Market for Reproductive Health / Fertility, 2022-2035
      • 13.4.1.6. Women's Digital Health Applications / Software Market for Others, 2022-2035
    • 13.4.2. Women's Digital Health Market for Applications / Software, 2022-2035: Distribution by Geography
      • 13.4.2.1. Women's Digital Health Applications / Software Market in North America, 2022-2035
      • 13.4.2.2. Women's Digital Health Applications / Software Market in Europe, 2022-2035
      • 13.4.2.3. Women's Digital Health Applications / Software Market in Asia-Pacific, 2022-2035
      • 13.4.2.4. Women's Digital Health Applications / Software Market in Latin America, 2022-2035
      • 13.4.2.5. Women's Digital Health Applications / Software Market in Middle East and North Africa, 2022-2035
      • 13.4.2.6. Women's Digital Health Applications / Software Market in Rest of the World, 2022-2035
    • 13.5.1. Women's Digital Health Market for Devices, 2022-2035: Distribution by Therapeutic Application Area
      • 13.5.1.1. Women's Digital Health Device Market for Fetal Health, 2022-2035
      • 13.5.1.2. Women's Digital Health Device Market for General Wellness, 2022-2035
      • 13.5.1.3. Women's Digital Health Device Market for Menstrual Cycle, 2022-2035
      • 13.5.1.4. Women's Digital Health Device Market for Pelvic Care, 2022-2035
      • 13.5.1.5. Women's Digital Health Device Market for Reproductive Health / Fertility, 2022-2035
      • 13.5.1.6. Women's Digital Health Device Market for Others, 2022-2035
    • 13.5.2. Women's Digital Health Market for Devices, 2022-2035: Distribution by Geography
      • 13.5.2.1. Women's Digital Health Device Market in North America, 2022-2035
      • 13.5.2.2. Women's Digital Health Device Market in Europe, 2022-2035
      • 13.5.2.3. Women's Digital Health Device Market in Asia-Pacific, 2022-2035
      • 13.5.2.4. Women's Digital Health Device Market in Latin America, 2022-2035
      • 13.5.2.5. Women's Digital Health Device Market in Middle East and North Africa, 2022-2035
      • 13.5.2.6. Women's Digital Health Device Market in Rest of the World, 2022-2035

14. ROLE OF DIGITALIZATION IN WOMEN'S LIFE

  • 14.1. Chapter Overview
  • 14.2. Evolution of Digital Solutions for Women during COVID-19 Pandemic
    • 14.2.1. Learning New Skills
  • 14.3. Opportunities in Professional and Personal Life
    • 14.3.1. Small Scale Online Businesses
    • 14.3.2. Demand for Online Financial Products
  • 14.4. Existing Digital Gender Gap
    • 14.4.1. Impact of AI on Digital Gender Gap
  • 14.5. Skills Shortfall
  • 14.6. Strengthening Ways for Digital Adoption among Women

15. DIGITAL TRENDS: RESHAPING THE FUTURE OF HEALTHCARE

  • 15.1. Chapter Overview
  • 15.2. Artificial Intelligence
    • 15.2.1. Role of Artificial Intelligence in Healthcare
    • 15.2.2. Digital Adoption: Companies employing Artificial Intelligence in Healthcare Solutions
  • 15.3. Machine Learning
    • 15.3.1. Role of Machine Learning in Healthcare
    • 15.3.2. Digital Adoption: Companies employing Machine Learning in
  • 15.4. Deep Learning
    • 15.4.1. Role of Deep Learning in Healthcare
  • 15.5. Metaverse
    • 15.5.1. Role of Metaverse in Healthcare
  • 15.6. Conclusion

16. CONCLUSION

17. EXECUTIVE INSIGHTS

  • 17.1. Chapter Overview
  • 17.2. iSONO Health
    • 17.2.1. Company Snapshot
    • 17.2.2. Interview Transcript: Maryam Ziaei, Founder and Chief Executive Officer
  • 17.3. Lisa Health
    • 17.3.1. Company Snapshot
    • 17.3.2. Interview Transcript: Ann Garnier, Founder and Chief Executive Officer
  • 17.4. Illumigyn
    • 17.4.1. Company Snapshot
    • 17.4.2. Interview Transcript: Honny Hillegonda Kipnis Groen, Chief Marketing Officer

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

  • Figure 2.1 Executive Summary: Current Market Landscape
  • Figure 2.2 Executive Summary: Funding and Investment Analysis
  • Figure 2.3 Executive Summary: Partnerships and Collaborations
  • Figure 2.4 Executive Summary: Global Events Analysis
  • Figure 2.5 Executive Summary: Product Development and Success Analysis
  • Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
  • Figure 3.1 Benefits of Digital Health Technologies
  • Figure 3.2 Women's Digital Health: Type of Solutions
  • Figure 3.3 Women's Digital Health: Challenges
  • Figure 4.1 Women's Digital Health: Distribution by Type of Solutions Offered / Available
  • Figure 4.2 Women's Digital Health: Distribution by Current Status of Development
  • Figure 4.3 Women's Digital Health: Distribution by Ratings of Women's Digital Health Applications
  • Figure 4.4 Women's Digital Health: Distribution by Therapeutic Application Area
  • Figure 4.5 Women's Digital Health: Distribution by Usage Period with respect to Pregnancy
  • Figure 4.6 Women's Digital Health: Distribution by Purpose
  • Figure 4.7 Women's Digital Health: Distribution by End-Users
  • Figure 4.8 Women's Digital Health: Distribution by Therapeutic Application Area and Type of Solution
  • Figure 4.9 Women's Digital Health Developers: Distribution by Year of Establishment
  • Figure 4.10 Women's Digital Health Developers: Distribution by Company Size
  • Figure 4.11 Women's Digital Health Developers: Distribution by Region of Headquarters
  • Figure 4.12 Women's Digital Health Developers: Distribution by Company Size and Region of Headquarters
  • Figure 4.13 Women's Digital Health Developers: Distribution by Location of Headquarters
  • Figure 4.14 Leading Players: Distribution by Number of Solutions
  • Figure 5.1 Garmin: Product / Service Portfolio
  • Figure 5.2 Garmin: Women's Digital Health Product / Service(s) Offered
  • Figure 5.3 Kindbody: Product / Service Portfolio
  • Figure 5.4 Kindbody: Women's Digital Health Product / Service(s) Offered
  • Figure 5.5 LetsGetChecked: Product / Service Portfolio
  • Figure 5.6 LetsGetChecked: Women's Digital Health Product / Service(s) Offered
  • Figure 5.7 Maven Clinic: Product / Service Portfolio
  • Figure 5.8 Maven Clinic: Women's Digital Health Product / Service(s) Offered
  • Figure 5.9 Ro: Product / Service Portfolio
  • Figure 5.10 Ro: Women's Digital Health Product / Service(s) Offered
  • Figure 5.11 Willow Innovations: Product / Service Portfolio
  • Figure 5.12 Willow Innovations: Women's Digital Health Product / Service(s) Offered
  • Figure 6.1 Flo Health: Product / Service Portfolio
  • Figure 6.2 Flo Health: Women's Digital Health Product / Service(s) Offered
  • Figure 6.3 Hubble Connected: Product / Service Portfolio
  • Figure 6.4 Hubble Connected: Women's Digital Health Product / Service(s) Offered
  • Figure 6.5 International Medical Center: Product / Service Portfolio
  • Figure 6.6 International Medical Center: Women's Digital Health Product / Service(s)Offered
  • Figure 7.1 Funding and Investment Analysis: Distribution by Year, Type of Funding and Amount Invested, 2016-2021 (USD Million)
  • Figure 7.2 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2016-2021
  • Figure 7.3 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, 2016-2021 (USD Million)
  • Figure 7.4 Funding and Investment Analysis: Distribution by Type of Funding
  • Figure 7.5 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Figure 7.6 Most Active Players: Distribution by Number of Funding Instances
  • Figure 7.7 Most Active Players: Distribution by Amount Raised (USD Million)
  • Figure 7.8 Key Investors: Analysis by Number of Instances
  • Figure 7.9 Funding and Investments Analysis: Distribution by Type of Solution
  • Figure 7.10 Funding and Investments: Distribution by Type of Solution and Amount Invested (USD Million)
  • Figure 7.11 Funding and Investment Analysis: Distribution of Amount Invested by Therapeutic Application Area (USD Million)
  • Figure 7.12 Funding and Investment Analysis: Geographical Distribution by Number of Instances and Amount Invested (USD Million)
  • Figure 7.13 Funding and Investment Analysis: Distribution by Year, Therapeutic Application Area and Amount Invested, 2016-2021 (USD Million)
  • Figure 7.14 Summary of Investments
  • Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022 (till January)
  • Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022 (till January)
  • Figure 8.7 Partnerships and Collaborations: Distribution by Type of Partner
  • Figure 8.6 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner, 2017-2022 (till January)
  • Figure 8.8 Partnerships and Collaborations: Distribution by Type of Partnership and Product / Solution
  • Figure 8.8 Most Active Players: Distribution by Number of Partnerships
  • Figure 8.9 Leading Players: Distribution by Type of Partnership
  • Figure 8.10 Partnerships and Collaborations: Regional Distribution
  • Figure 8.11 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Figure 9.1 Start-up Health Indexing: Distribution by Type of Product / Solution
  • Figure 9.2 Start-up Health Indexing: Distribution by Therapeutic Application Area
  • Figure 9.3 Start-up Health Indexing: Distribution by Usage Period with respect to Pregnancy
  • Figure 9.4 Start-up Health Indexing: Distribution by Partnership Activity
  • Figure 9.5 Start-up Health Indexing: Distribution by Funding Activity
  • Figure 9.6 Start-up Health Indexing: Distribution by Progression in Funding
  • Figure 9.7 Start-up Health Indexing: Distribution by Type of Funding
  • Figure 9.8 Start-up Health Indexing: Distribution by Location of Headquarters
  • Figure 9.9 Start-up Health Indexing: Roots Analysis Perspective
  • Figure 10.1 Global Events: Cumulative Half Yearly Trend, H2 2018 - 2022
  • Figure 10.2 Global Events: Distribution by Event Platform
  • Figure 10.3 Global Events: Distribution by Type of Event
  • Figure 10.4 Global Events: Distribution by Location of Event
  • Figure 10.5 Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Areas
  • Figure 10.6 Global Events: Historical Trend of Event Agendas, H2 2018 - 2022
  • Figure 10.7 Most Active Event Organizers: Distribution by Number of Events
  • Figure 10.8 Most Active Industry Participants: Distribution by Number of Events
  • Figure 10.9 Global Events: Distribution by Designation of Participant
  • Figure 10.10 Global Events: Distribution by Affiliated Department of Participant
  • Figure 10.11 Most Active Speakers: Distribution by Number of Events
  • Figure 10.12 Global Events: Geographical Mapping of Upcoming Events
  • Figure 11.1 Women's Digital Health: SWOT Analysis
  • Figure 11.2 Comparison of SWOT Factors
  • Figure 12.1 Roadmap for the Development of Women's Digital Health Application
  • Figure 12.2 Roadmap for the Development of Women's Digital Health Device
  • Figure 12.3 Women's Digital Health: Unmet Needs
  • Figure 13.1 Overall Women's Digital Health Market, 2022-2035 (USD Billion)
  • Figure 13.2 Women's Digital Health Market, 2022-2035: Distribution by Type of Solution (USD Million)
  • Figure 13.3 Women's Digital Health Market for Applications / Software, 2022-2035 (USD Million)
  • Figure 13.4 Women's Digital Health Market for Devices, 2022-2035 (USD Million)
  • Figure 13.5 Women's Digital Health Market for Services Offered / Available, 2022-2035 (USD Million)
  • Figure 13.6 Women's Digital Health Market for Applications / Software, 2022-2035: Distribution by Therapeutic Application Area (USD Million)
  • Figure 13.7 Women's Digital Health Applications / Software Market for Fetal Health, 2022-2035 (USD Million)
  • Figure 13.8 Women's Digital Health Applications / Software Market for General Wellness, 2022-2035 (USD Million)
  • Figure 13.9 Women's Digital Health Applications / Software Market for Menstrual Cycle, 2022-2035 (USD Million)
  • Figure 13.10 Women's Digital Health Applications / Software Market for Pelvic Care, 2022-2035 (USD Million)
  • Figure 13.11 Women's Digital Health Applications / Software Market for Reproductive Health / Fertility, 2022-2035 (USD Million)
  • Figure 13.12 Women's Digital Health Applications / Software Market for Others, 2022-2035 (USD Million)
  • Figure 13.13 Women's Digital Health Market for Applications / Software, 2022-2035: Distribution by Geography (USD Million)
  • Figure 13.14 Women's Digital Health Applications / Software Market in North America, 2022-2035 (USD Million)
  • Figure 13.15 Women's Digital Health Applications / Software Market in Europe, 2022-2035 (USD Million)
  • Figure 13.16 Women's Digital Health Applications / Software Market in Asia-Pacific, 2022-2035 (USD Million)
  • Figure 13.17 Women's Digital Health Applications / Software Market in Latin America, 2022-2035 (USD Million)
  • Figure 13.18 Women's Digital Health Applications / Software Market in Middle East and North Africa, 2022-2035 (USD Million)
  • Figure 13.19 Women's Digital Health Applications / Software Market in Rest of the World, 2022-2035 (USD Million)
  • Figure 13.20 Women's Digital Health Market for Devices, 2022-2035: Distribution by Therapeutic Application Area (USD Million)
  • Figure 13.21 Women's Digital Health Device Market for Fetal Health, 2022-2035 (USD Million)
  • Figure 13.22 Women's Digital Health Device Market for General Wellness, 2022-2035 (USD Million)
  • Figure 13.23 Women's Digital Health Device Market for Menstrual Cycle, 2022-2035 (USD Million)
  • Figure 13.24 Women's Digital Health Device Market for Pelvic Care, 2022-2035 (USD Million)
  • Figure 13.25 Women's Digital Health Device Market for Reproductive Health / Fertility, 2022-2035 (USD Million)
  • Figure 13.26 Women's Digital Health Device Market for Others, 2022-2035 (USD Million)
  • Figure 13.27 Women's Digital Health Market for Devices, 2022-2035: Distribution by Geography (USD Million)
  • Figure 13.28 Women's Digital Health Device Market in North America, 2022-2035 (USD Million)
  • Figure 13.29 Women's Digital Health Device Market in Europe, 2022-2035 (USD Million)
  • Figure 13.30 Women's Digital Health Device Market in Asia-Pacific, 2022-2035 (USD Million)
  • Figure 13.31 Women's Digital Health Device Market in Latin America, 2022-2035 (USD Million)
  • Figure 13.32 Women's Digital Health Device Market in Middle East and North Africa, 2022-2035 (USD Million)
  • Figure 13.33 Women's Digital Health Device Market in Rest of the World, 2022-2035 (USD Million)
  • Figure 14.1 Evolution of Digital Concept Among Women: Role of Digitalization in Women's Life during COVID-19 Pandemic
  • Figure 14.2 Evolution of Digital Concept Among Women: Demand for Online Financial Products
  • Figure 14.3 Evolution of Digital Concept Among Women: Unequal Opportunities in Jobs
  • Figure 14.4 Evolution of Digital Concept Among Women: Skills Shortfall
  • Figure 14.5 Evolution of Digital Concept Among Women: Strengthening Ways for the Digital Inclusion among Women
  • Figure 15.1 Digital Adoption: Applications of Artificial Intelligence in Healthcare
  • Figure 15.2 Digital Adoption: Applications of Machine Learning in Healthcare
  • Figure 15.3 Digital Adoption: Applications of Deep Learning in Healthcare
  • Figure 15.4 Digital Adoption: Applications of Metaverse in Healthcare

List Of Tables

  • Table 4.1 Women's Digital Health: Information on Type of Solution and Therapeutic Application Area
  • Table 4.2 Women's Digital Health: Information on Current Status of Development and Ratings of Women's Digital Health Applications
  • Table 4.3 Women's Digital Health: Information on Usage in Pregnancy, Purpose and End-Users
  • Table 4.4 Women's Digital Health: Developer Landscape
  • Table 5.1 Women's Digital Health Market in North America: List of Companies Profiled
  • Table 5.2 Garmin: Company Snapshot
  • Table 5.3 Kindbody: Company Snapshot
  • Table 5.4 Kindbody: Recent Developments and Future Outlook
  • Table 5.5 LetsGetChecked: Company Snapshot
  • Table 5.6 LetsGetChecked: Recent Developments and Future Outlook
  • Table 5.7 Maven Clinic: Company Snapshot
  • Table 5.8 Maven Clinic: Recent Developments and Future Outlook
  • Table 5.9 Ro: Company Snapshot
  • Table 5.10 Ro: Recent Developments and Future Outlook
  • Table 5.11 Willow Innovations: Company Snapshot
  • Table 6.1 Women's Digital Health Market in Europe, Asia-Pacific and Middle East & North Africa: List of Companies Profiled
  • Table 6.2 Flo Health: Company Snapshot
  • Table 6.3 Flo Health: Recent Developments and Future Outlook
  • Table 6.4 Hubble Connected: Company Snapshot
  • Table 6.5 International Medical Center: Company Snapshot
  • Table 7.1 List of Funding Instances, 2016-2021: Information on Company, Year of Funding, Type, Amount Invested and Investors
  • Table 7.2 List of Funding Instances, 2016-2021: Information on Solutions and Therapeutic Application Area
  • Table 8.1 Women's Digital Health: List of Partnerships and Collaborations, 2017-2022 (till January)
  • Table 10.1 List of Global Events related to Women's Digital Health
  • Table 15.1 Digital Adoption: Companies employing Artificial Intelligence in Healthcare
  • Table 15.2 Digital Adoption: Companies employing Machine Learning in Healthcare
  • Table 17.1 iSONO Health: Company Snapshot
  • Table 17.2 Lisa Health: Company Snapshot
  • Table 17.3 Illumigyn: Company Snapshot
  • Table 18.1 Women's Digital Health: Distribution by Type of Solutions Offered / Available
  • Table 18.2 Women's Digital Health: Distribution by Current Status of Development
  • Table 18.3 Women's Digital Health: Distribution by Ratings of Women's Digital Health Applications
  • Table 18.4 Women's Digital Health: Distribution by Therapeutic Application Area
  • Table 18.5 Women's Digital Health: Distribution by Usage Period with respect to Pregnancy
  • Table 18.6 Women's Digital Health: Distribution by Purpose
  • Table 18.7 Women's Digital Health: Distribution by End-Users
  • Table 18.8 Women's Digital Health: Distribution by Application Area and Type of Solution
  • Table 18.9 Women's Digital Health Developers: Distribution by Year of Establishment
  • Table 18.10 Women's Digital Health Developers: Distribution by Company Size
  • Table 18.11 Women's Digital Health Developers: Distribution by Region of Headquarters
  • Table 18.12 Women's Digital Health Developers: Distribution by Company Size and Region of Headquarters
  • Table 18.13 Women's Digital Health Developers: Distribution by Location of Headquarters
  • Table 18.14 Leading Players: Distribution by Number of Solutions
  • Table 18.15 Funding and Investment Analysis: Distribution by Year, Type of Funding and Amount Invested, 2016-2021 (USD Million)
  • Table 18.16 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2016-2021
  • Table 18.17 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, 2016-2021 (USD Million)
  • Table 18.18 Funding and Investment Analysis: Distribution by Type of Funding
  • Table 18.19 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
  • Table 18.20 Most Active Players: Distribution by Number of Funding Instances
  • Table 18.21 Most Active Players: Distribution by Amount Raised (USD Million)
  • Table 18.22 Key Investors: Analysis by Number of Instances
  • Table 18.23 Funding and Investments Analysis: Distribution by Solution
  • Table 18.24 Funding and Investments: Distribution by Type of Solution and Amount Invested (USD Million)
  • Table 18.25 Funding and Investment Analysis: Distribution of Amount Invested by Therapeutic Application Area (USD Million)
  • Table 18.26 Funding and Investment Analysis: Geographical Distribution by Number of Instances and Amount Invested (USD Million)
  • Table 18.27 Funding and Investment Analysis: Distribution by Year, Therapeutic Application Area and Amount Invested, 2016-2021 (USD Million)
  • Table 18.28 Summary of Investments
  • Table 18.29 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022 (till January)
  • Table 18.30 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 18.31 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022 (till January)
  • Table 18.32 Partnerships and Collaborations: Distribution by Type of Partner
  • Table 18.33 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner, 2017-2022 (till January)
  • Table 18.34 Partnerships and Collaborations: Distribution by Type of Partnership and Product / Solution
  • Table 18.35 Most Active Players: Distribution by Number of Partnerships
  • Table 18.36 Leading Players: Distribution by Type of Partnership
  • Table 18.37 Partnerships and Collaborations: Regional Distribution
  • Table 18.38 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Table 18.39 Global Events: Cumulative Half Yearly Trend, H2 2018 - 2022
  • Table 18.40 Global Events: Distribution by Event Platform
  • Table 18.41 Global Events: Distribution by Type of Event
  • Table 18.42 Global Events: Distribution by Location of Event
  • Table 18.43 Global Events: Historical Trend of Event Agendas, H2 2018 - 2022
  • Table 18.44 Most Active Event Organizers: Distribution by Number of Events
  • Table 18.45 Most Active Industry Participants: Distribution by Number of Events
  • Table 18.46 Global Events: Distribution by Designation of Participant
  • Table 18.47 Global Events: Distribution by Affiliated Department of Participant
  • Table 18.48 Most Active Speakers: Distribution by Number of Events
  • Table 18.49 Overall Women's Digital Health Market, 2022-2035 (USD Million)
  • Table 18.50 Women's Digital Health Market, 2022-2035: Distribution by Type of Solution (USD Million)
  • Table 18.51 Women's Digital Health Market for Applications / Software, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.52 Women's Digital Health Market for Devices, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.53 Women's Digital Health Market for Services Offered / Available, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.54 Women's Digital Health Market for Applications / Software, 2022-2035: Distribution by Therapeutic Application Area (USD Million)
  • Table 18.55 Women's Digital Health Applications / Software Market for Fetal Health, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.56 Women's Digital Health Applications / Software Market for General Wellness, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.57 Women's Digital Health Applications / Software Market for Menstrual Cycle, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.58 Women's Digital Health Applications / Software Market for Pelvic Care, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.59 Women's Digital Health Applications / Software Market for Reproductive Health / Fertility, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.60 Women's Digital Health Applications / Software Market for Others, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.61 Women's Digital Health Market for Applications / Software, 2022-2035: Distribution by Geography (USD Million)
  • Table 18.62 Women's Digital Health Applications / Software Market in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.63 Women's Digital Health Applications / Software Market in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.64 Women's Digital Health Applications / Software Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.65 Women's Digital Health Applications / Software Market in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.66 Women's Digital Health Applications / Software Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.68 Women's Digital Health Market for Devices, 2022-2035: Distribution by Therapeutic Application Area (USD Million)
  • Table 18.69 Women's Digital Health Device Market for Fetal Health, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.70 Women's Digital Health Device Market for General Wellness, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.71 Women's Digital Health Device Market for Menstrual Cycle, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.72 Women's Digital Health Device Market for Pelvic Care, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.73 Women's Digital Health Device Market for Reproductive Health / Fertility, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.74 Women's Digital Health Device Market for Others, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.75 Women's Digital Health Market for Devices, 2022-2035: Distribution by Geography (USD Million)
  • Table 18.76 Women's Digital Health Device Market in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.77 Women's Digital Health Device Market in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.78 Women's Digital Health Device Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.79 Women's Digital Health Device Market in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
  • Table 18.80 Women's Digital Health Device Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  • 1. 2048 Ventures
  • 2. 4FO Ventures
  • 3. 8VC
  • 4. a thousand colibris
  • 5. Aavia
  • 6. Advanced Maternity Innovations
  • 7. AH Trust
  • 8. Aindra Systems
  • 9. Alife Health
  • 10. Allara Health
  • 11. Alpha Femtech
  • 12. Alsace Business Angels
  • 13. AltaIR Capital
  • 14. Althea Group
  • 15. Altitude Ventures
  • 16. Alumni Ventures
  • 17. Amadeus Capital Partners
  • 18. Amboy Street Ventures
  • 19. Anastasia Kovba
  • 20. Anchorless Bangladesh
  • 21. Andera Partners
  • 22. AngelList Venture
  • 23. Anthem
  • 24. AOA
  • 25. Astute
  • 26. Autonomous Open Innovation (AOI)
  • 27. App Basic
  • 28. Apricity
  • 29. Arbor Health
  • 30. ArlanWasHere Investments
  • 31. Artesian
  • 32. Ascension Ventures
  • 33. ASPIVIX
  • 34. Asset Management Ventures
  • 35. Astinno
  • 36. Athena
  • 37. Atheneum
  • 38. Atlantic Therapeutics
  • 39. AtlasV Global
  • 40. Atomico
  • 41. Ava
  • 42. Avaana Capital
  • 43. Avestria Ventures
  • 44. Awesome People Ventures
  • 45. AXA
  • 46. Baby2Body
  • 47. Babyscripts
  • 48. Backstage Capital
  • 49. Balance
  • 50. Balderton Capital
  • 51. BBG Ventures
  • 52. Beehive Holdings
  • 53. Bellabeat
  • 54. Bethnal Green Ventures
  • 55. BGF
  • 56. Bia Med
  • 57. Blackbird Ventures
  • 58. Bloomer Tech
  • 59. Bloomlife
  • 60. Bloomth
  • 61. Blossom Capital
  • 62. Blue Cross Blue Shield of Massachusetts
  • 63. Blue Ox Healthcare Partners
  • 64. BlueRun Ventures
  • 65. Bolt Ventures
  • 66. Bonnier Ventures
  • 67. Bonzun
  • 68. Borski Fund
  • 69. Braster
  • 70. BrightCap Ventures
  • 71. Brilliantly
  • 72. btov Partners
  • 73. B-wom
  • 74. Cambridge Design Partnership
  • 75. Cambridge Digital Health
  • 76. Cambridge Femtech Society
  • 77. Candlelit
  • 78. Canopie
  • 79. Capier Investments
  • 80. Carbomed Medical Solutions
  • 81. Care4Cute
  • 82. CareSignal
  • 83. Carrot
  • 84. Casdin Capital
  • 85. Cayaba Care
  • 86. Charles River Ventures
  • 87. Chiaroscuro Foundation
  • 88. Chorus Health
  • 89. Cigna Ventures
  • 90. Claritas Health Ventures
  • 91. Clementine
  • 92. Clue
  • 93. Collaborative Fund
  • 94. Company Ventures
  • 95. Conference Series
  • 96. Connors Centre
  • 97. Coroflo
  • 98. Cortado Ventures
  • 99. Council For Trade and Investment Promotion (CTIP)
  • 100. COYA Partners
  • 101. Creative Destruction Lab
  • 102. Crescent Ridge Partners
  • 103. Development Bank of Wales
  • 104. Digital Health Today
  • 105. DigiTx Partners
  • 106. Downing Ventures
  • 107. Dragoneer Investment Group
  • 108. Dream Incubator
  • 109. drip. menstrual cycle and fertility tracking
  • 110. Ease Healthcare
  • 111. Efficient Capacity
  • 112. EIT Health
  • 113. ElaWoman
  • 114. Elda Health
  • 115. Eli Health
  • 116. Elidah
  • 117. EloCare
  • 118. Elvie
  • 119. Elysium Venture Capital
  • 120. Embr
  • 121. Emme
  • 122. Endeavour Vision
  • 123. Endodiag
  • 124. Endometrix
  • 125. Enterprise Ireland
  • 126. Enzia Ventures
  • 127. EQT Ventures
  • 128. eQventure
  • 129. European Commission
  • 130. European Innovation Council and SMEs Executive Agency (EISMEA)
  • 131. Evernow
  • 132. Exandus
  • 133. Faegre Drinker
  • 134. Fairhaven Health
  • 135. Femasys
  • 136. Femcare - Reverse PCOS, Consult Doctor Online
  • 137. Femcy
  • 138. FEMM
  • 139. FEMNA
  • 140. Femometer
  • 141. FemTech Analytics
  • 142. Femtech Focus
  • 143. FemTec Healthcare
  • 144. FemX
  • 145. Ferne
  • 146. Fertility Focus
  • 147. FetoLife
  • 148. First Round Capital
  • 149. FirstCheck Africa
  • 150. FirstMark Capital
  • 151. Fish & Richardson
  • 152. Fizimed
  • 153. Flare Capital Partners
  • 154. Flint Capital
  • 155. Flo Health
  • 156. Flöka
  • 157. Fondation pour l'Innovation Technologique (FIT)
  • 158. Forerunner Ventures
  • 159. Foresight Group
  • 160. Fortunis Capital
  • 161. Founder Institute
  • 162. Founders Fund
  • 163. Foview
  • 164. Frame Fertility
  • 165. Frost & Sullivan
  • 166. Frøya
  • 167. Fuel Ventures
  • 168. Future Positive Capital
  • 169. Gals Bio
  • 170. Garmin
  • 171. gBETA Medtech
  • 172. Gedeon Richter
  • 173. General Catalyst
  • 174. Gennev
  • 175. Global Founders Capital
  • 176. Glow
  • 177. Google
  • 178. Grand Central Tech
  • 179. Greycroft
  • 180. GSK NEXT
  • 181. GV
  • 182. Hackster
  • 183. Halza
  • 184. Hambrecht Ducera Growth Ventures
  • 185. Harvard Business School Association of Northern California (HBSANC)
  • 186. Harvard Medical School
  • 187. Harvard University
  • 188. HAX
  • 189. Haxus
  • 190. Health & Her
  • 191. Health Enterprise Partners (HEP)
  • 192. Health in Her HUE
  • 193. HealthXL
  • 194. HeraMED
  • 195. Hikma Ventures
  • 196. HITLAB
  • 197. Hiventures
  • 198. HLM Venture Partners
  • 199. Horizon 2020
  • 200. Hubble Connected
  • 201. Hybrid4apps
  • 202. iBreve
  • 203. Icon Ventures
  • 204. Illumigyn
  • 205. Illumina Ventures
  • 206. iMama
  • 207. Impact Ventures UK
  • 208. Information Technology Academia Collaboration (ITAC)
  • 209. Inito
  • 210. Inne
  • 211. Innovate UK
  • 212. Inova Health System
  • 213. Insignia Ventures Partners
  • 214. International Medical Center Apps
  • 215. IPOPEMA Securities
  • 216. iSono Health
  • 217. Iterative Capital
  • 218. iXensor
  • 219. January Ventures
  • 220. Jennis
  • 221. Johnson Venture Partners (JVP)
  • 222. Kamet Ventures
  • 223. kegg
  • 224. Kheiron Medical Technologies
  • 225. Khyria
  • 226. Kindbody
  • 227. Konna
  • 228. Kormeli
  • 229. LabQ International
  • 230. Lactamo
  • 231. LactApp
  • 232. Lactation Lab
  • 233. LAIA
  • 234. Leap Fitness Group
  • 235. Leerink Transformation Partners
  • 236. Lemonaid Health
  • 237. LetsGetChecked
  • 238. Life Science Innovation Fund
  • 239. LifeSense Group (LSG)
  • 240. Linchpin Healthcare
  • 241. Lisa Health
  • 242. Livia
  • 243. League of Innovators
  • 244. LSP
  • 245. Lucina Analytics
  • 246. Luma Womb
  • 247. Lux Capital
  • 248. Mabel
  • 249. Mae
  • 250. Magnetic Ventures
  • 251. Mahmee
  • 252. Maki.vc
  • 253. Mangrove Capital Partners
  • 254. MassChallenge
  • 255. Material Impact
  • 256. Materna Medical
  • 257. Maven Clinic
  • 258. Maven Ventures
  • 259. Maveron
  • 260. Maya
  • 261. McKinsey
  • 262. MEDITA
  • 263. Medtech Women
  • 264. MemorialCare Innovation Fund (MCIF)
  • 265. Menopod
  • 266. Merchavia
  • 267. Meridian Street Capital
  • 268. Meritech Capital Partners
  • 269. Meta
  • 270. Metronomic
  • 271. Microsoft
  • 272. Midlands Engine Investment Fund (MEIF)
  • 273. MiMARK
  • 274. Miracare
  • 275. Mirco Bettelini
  • 276. Massachusetts Institute of Technology (MIT)
  • 277. MMD
  • 278. MobileODT
  • 279. Modern Fertility
  • 280. Monkfish Equity
  • 281. MooDoos Investments
  • 282. Moonai
  • 283. Modern Fertility
  • 284. MUTU
  • 285. My Ava
  • 286. Nabta Health
  • 287. National Cancer Institute (NCI)
  • 288. National Education Association (NEA)
  • 289. National Health Service (NHS)
  • 290. National Institutes of Health (NIH)
  • 291. National Science Foundation (NSF)
  • 292. Natural Cycles
  • 293. Naytal
  • 294. Nest Collaborative
  • 295. New England-Israel Business Council (NEIBC)
  • 296. Nex Cubed
  • 297. Nexus Venture Partners
  • 298. NGP Capital
  • 299. Niramai
  • 300. Nordic Eye Venture Capital
  • 301. Novartis Venture Fund
  • 302. NursElet
  • 303. Nuvo Group
  • 304. Oak HC/FT
  • 305. Oath Care
  • 306. OCON Healthcare
  • 307. Octopus Ventures
  • 308. Oky
  • 309. Olive Tree Ventures
  • 310. Oova
  • 311. Optum Ventures
  • 312. Oratel Diagnostics
  • 313. OrbiMed Advisors
  • 314. Ordinary Folk
  • 315. Orreco
  • 316. OSF Ventures
  • 317. Oshihar Apps
  • 318. Oula
  • 319. Ovia Health
  • 320. Ovira
  • 321. Ovulai
  • 322. Ovulation Calculator
  • 323. Pachamama
  • 324. Parentlane
  • 325. Parian Global Management
  • 326. Partum Health
  • 327. Pepapp
  • 328. Peramare Enterprises
  • 329. Perceptive Advisors
  • 330. PeriGen
  • 331. Phenomenal Women's Health
  • 332. pi Ventures
  • 333. Plackal Tech
  • 334. Plug and Play Tech Centre
  • 335. Polytech Ventures
  • 336. Pomelo Care
  • 337. Pontifax Venture Capital
  • 338. PreemieWorld
  • 339. PregnaScan
  • 340. Prima-Temp
  • 341. Prime Venture Partners
  • 342. Privia Health
  • 343. Proactive for her
  • 344. Proov
  • 345. Public Policy Projects (PPP)
  • 346. pumpspotting
  • 347. Punchbowl
  • 348. Qiming Venture Partners
  • 349. Qualcomm Life
  • 350. Raiing Medical
  • 351. Raydiant Oximetry
  • 352. Renalis
  • 353. Renovia
  • 354. Rhia Ventures
  • 355. Ro
  • 356. Roche
  • 357. Royal Philips
  • 358. RRE Ventures
  • 359. Sagentia Innovation
  • 360. Salem Partners
  • 361. Santora Nakama
  • 362. Scientific Federation
  • 363. SD Venture
  • 364. Seashore Solutions
  • 365. Sequoia Capital
  • 366. Sera Prognostics
  • 367. Serena Ventures
  • 368. Seroba Life Sciences
  • 369. Sevenlogics
  • 370. Shareholder Value Management
  • 371. She Loves Tech
  • 372. SOSV
  • 373. Spring Mountain Capital
  • 374. Springboard Enterprises
  • 375. Srirakshaa Healthcare
  • 376. Starting Line
  • 377. StartUp Health
  • 378. State of Maine
  • 379. SteadySense
  • 380. SteelSky Ventures
  • 381. Storka
  • 382. Summit Reinsurance Services
  • 383. SVC
  • 384. Swiss Healthcare Startups (SHS)
  • 385. Syrona Health
  • 386. Tamtris Web Services
  • 387. Target Global
  • 388. Tech Up For Women
  • 389. Tech4Eva
  • 390. Techammer
  • 391. Techstars
  • 392. Tempdrop
  • 393. Texas HALO Fund
  • 394. The Body Literacy Collective
  • 395. The Female Health Hub
  • 396. International Technology Law Association (ITechLaw)
  • 397. The Lily Project
  • 398. The Pelvic Expert
  • 399. Royal Society
  • 400. Royal Society of Medicine
  • 401. Yozma
  • 402. Think Bigger Capital
  • 403. Tia
  • 404. Tiger Global Management
  • 405. Titan Capital
  • 406. Tooly Tech
  • 407. TruDiary
  • 408. True Ventures
  • 409. Tutorify
  • 410. U.S. Venture Partners
  • 411. Ubicom Holdings
  • 412. Uncork Capital
  • 413. Union Square Ventures
  • 414. United Nations University International Institute for Global Health (UNU-IIGH)
  • 415. UnityPoint Health Ventures
  • 416. University Hospitals
  • 417. Uvi Health
  • 418. VCapital
  • 419. Vectr Ventures
  • 420. Veera Health
  • 421. Velmio
  • 422. Venture Kick
  • 423. Victorum Capital Club
  • 424. Vivant
  • 425. VNV Global
  • 426. Vulvy
  • 427. Wachanga
  • 428. Walking Ventures
  • 429. Watkins-Conti Products
  • 430. Wavemaker 360
  • 431. Western Development Commission
  • 432. Wildflower Health
  • 433. Willow
  • 434. Women in Technology International WITI
  • 435. Women In Bio
  • 436. Women in Data
  • 437. Women of Wearables (WoW)
  • 438. Women's Health Connecticut
  • 439. WomenUP
  • 440. Woom
  • 441. Xpectives.Health
  • 442. Y Combinator
  • 443. Yesmom
  • 444. Ysios Capital
  • 445. Zaya
  • 446. Zero Mothers Die
  • 447. Zoie Health
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!